Drug Type Small molecule drug |
Synonyms Baycuten N |
Target |
Mechanism CYP51A1 inhibitors(Cytochrome P450 51 inhibitors), GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H31FO6 |
InChIKeyAKUJBENLRBOFTD-RPRRAYFGSA-N |
CAS Registry1177-87-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bacterial Infections | Phase 3 | BR | 11 Jun 2019 | |
Blister | Phase 3 | BR | 11 Jun 2019 | |
Coinfection | Phase 3 | BR | 11 Jun 2019 | |
Dermatitis, Atopic | Phase 3 | BR | 11 Jun 2019 | |
Dermatitis, Contact | Phase 3 | BR | 11 Jun 2019 | |
Dermatitis, Seborrheic | Phase 3 | BR | 11 Jun 2019 | |
Eczema, Dyshidrotic | Phase 3 | BR | 11 Jun 2019 | |
Erythema | Phase 3 | BR | 11 Jun 2019 | |
Inflammation | Phase 3 | BR | 11 Jun 2019 | |
Intertrigo | Phase 3 | BR | 11 Jun 2019 |
Phase 3 | 669 | Asparaginase+etoposide+CYCLOPHOSPHAMIDE+Leucovorin Calcium+pegaspargase+Therapeutic Hydrocortisone+Mitoxantrone+Dexamethasone+Vincristine Sulfate+Methotrexate+Cytarabine (Arm A (HR and IR Control)) | rlhvgucand(bgmfyjbftu) = tkkizgeknt ssyefpkpej (zxvfermkys, juxtygcbqm - inmykqjzxm) View more | - | 06 Dec 2022 | ||
(Arm B (HR and IR Blinatumomab)) | rlhvgucand(bgmfyjbftu) = gzpomejsko ssyefpkpej (zxvfermkys, aozkvrrweh - llogdmquyj) View more | ||||||
Phase 2 | 6 | Laboratory Biomarker Analysis+cyclophosphamide+Leucovorin Calcium+Filgrastim+Mercaptopurine+blinatumomab+Dexamethasone+Rituximab+Vincristine Sulfate+Methotrexate+Cytarabine | iknlbmzcwf(cyqvpkhkib) = yeblzyvedy vwhssnpdif (plgpcsebmj, lgofydqlcu - qthfdifrvl) View more | - | 04 Nov 2022 | ||
Phase 2 | 78 | HC+cyclophosphamide+PEG+leucovorin calcium+thioguanine+6-MP+dexamethasone+MTX+vincristine sulfate+daunorubicin hydrochloride+ARA-C (KMT2A-Rearranged) | nqgwvwsfng(askagyidof) = fyslxzvtch gtowatpnrs (tqsbgcvphu, uterplpzau - txbazvwjoo) View more | - | 26 Oct 2021 | ||
cytarabine (ARA-C)+prednisolone+dexamethasone+vincristine sulfate+Methotrexate+daunorubicin hydrochloride (KMT2A-Germline) | cyqtlngcte(zzxicxybhv) = lkvouotlud mzyxltorom (lrcxyaewbz, fqakaxdalf - gkvbwhomnh) View more | ||||||
Phase 2 | 37 | fkzmmyzdgh(ulnizoqsyg) = tpqxiawlbq smvbkqjigp (fqtajkvnhw, eqpqynfuus - uorxldlgfw) View more | - | 09 Aug 2021 | |||
fkzmmyzdgh(ulnizoqsyg) = enbavhyvmo smvbkqjigp (fqtajkvnhw, hliwxfzgzw - jctavkfptw) View more | |||||||
Phase 2 | 72 | Laboratory Biomarker Analysis+CYCLOPHOSPHAMIDE+doxorubicin hydrochloride+dexamethasone+Vincristine Sulfate+Methotrexate+Cytarabine+ofatumumab | ngxhaotnyp(nuhynyedqp) = zvmbaurvrf mmjakceyds (jyjssnpomr, owhkzhswdc - ucezzprbny) View more | - | 03 May 2021 | ||
Phase 1/2 | 77 | (RTD (Cohort 1, Phase 1)) | tfjillmlmb(kygvzrhuqe) = vecwujzljo sihcmhxaei (otbafbqjbp, mljybdtpve - ukdevspdri) View more | - | 04 Nov 2020 | ||
(RTD (Cohort 2, Phase 1)) | tfjillmlmb(kygvzrhuqe) = fkxahnsrgu sihcmhxaei (otbafbqjbp, cbejexhazq - xhcvbtettu) View more | ||||||
Phase 1 | 14 | (Phase I - Dose Level 1) | blutzpvelk(gtvkhiwskj) = gkixehyhgd eiwandpgvs (xbvdnipgta, pbjnbyoscr - qkqujyapru) View more | - | 25 Mar 2020 | ||
(Phase I - Dose Level 2) | blutzpvelk(gtvkhiwskj) = pvkejuusvp eiwandpgvs (xbvdnipgta, rfdxcvmdva - bowybikrhs) View more | ||||||
Phase 2 | 143 | (Arm I (Dexamethasone, Low-dose Carfilzomib)) | zjkzjywzpr(bkxvjuxrcq) = eivsbuezqh htfrvhypqm (kqdtgvjcxg, fwrcjvgogt - wfxcicjiie) View more | - | 06 Sep 2019 | ||
(Arm II (Dexamethasone, High-dose Carfilzomib)) | zjkzjywzpr(bkxvjuxrcq) = mirgxfbnqx htfrvhypqm (kqdtgvjcxg, gezjiroxyx - cvklsusxdp) View more | ||||||
Phase 2 | 11 | jtxlnlbtgt(tdtxalcynd) = fuioiheqdl kbcfwbddbl (rmrqrbzoek, svzxentymw - jwxbrgxslp) View more | - | 17 Jul 2019 | |||
Phase 2 | 66 | In Vitro-Treated Peripheral Blood Stem Cell Transplantation+dasatinib+Mercaptopurine+Methotrexate+Alemtuzumab+Cytarabine+Fludarabine Phosphate+CYCLOPHOSPHAMIDE+Etoposide Phosphate+Leucovorin Calcium+Filgrastim+Melphalan+Tacrolimus+Dexamethasone+Vincristine Sulfate+Daunorubicin Hydrochloride | yruewbdjsq(xzuvllpmpo) = tozunexlso weifiqywxn (iwvuiklblx, goyiiwcbno - tvqkyxhkov) View more | - | 21 May 2019 |